ImmunityBio (IBRX) Gains from Investment Securities (2013 - 2026)
ImmunityBio (IBRX) reported Gains from Investment Securities of $10.0 million for Q1 2026, up 16029.03% year-over-year from N/an in Q1 2025, and up 5447.59% on a QoQ basis from -$187000.0 in Q4 2025.
ImmunityBio (IBRX) has 14 years of Gains from Investment Securities data on file, last reported at $10.0 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 16029.03% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.0 million (up 37.95% YoY) and the FY2024 annual result came in at $64000.0, changed N/A from the prior year.
- Gains from Investment Securities rose to $10.0 million in Q1 2026 per IBRX's latest filing, from -$187000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $19.3 million in Q2 2024 and bottomed at -$31.3 million in Q3 2024.
- The 5-year median for Gains from Investment Securities is -$241000.0 (2023), against an average of -$2.8 million.
- The widest annual swing landed in 2024, when Gains from Investment Securities plunged 281.37%; it then surged 16029.03% in 2026.
- Tracing IBRX's Gains from Investment Securities over 5 years: stood at -$13.2 million in 2022, then soared by 110.52% to $1.4 million in 2023, then sank by 281.37% to -$2.5 million in 2024, then jumped by 92.56% to -$187000.0 in 2025, then jumped by 5447.59% to $10.0 million in 2026.
- Per Business Quant, the three latest IBRX Gains from Investment Securities figures stand at $10.0 million (Q1 2026), -$187000.0 (Q4 2025), and -$14.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.00 Mn |
| Mar 31, 2026 | 10.00 Mn |
| Dec 31, 2025 | -187,000.00 |
| Dec 31, 2025 | -187,000.00 |
| Sep 30, 2025 | -14.91 Mn |
| Sep 30, 2025 | -14.91 Mn |
| Jun 30, 2025 | -3.89 Mn |
| Jun 30, 2025 | -3.89 Mn |
| Mar 31, 2025 | 62,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | -2.51 Mn |
| Dec 31, 2024 | -2.51 Mn |
| Sep 30, 2024 | -31.32 Mn |
| Sep 30, 2024 | -31.32 Mn |
| Jun 30, 2024 | 19.30 Mn |
| Jun 30, 2024 | 19.30 Mn |
| Mar 31, 2024 | 21,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 1.39 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | -14.27 Mn |
| Sep 30, 2023 | -14.27 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Jun 30, 2023 | 10.02 Mn |
| Mar 31, 2023 | -295,000.00 |
| Mar 31, 2023 | -295,000.00 |
| Dec 31, 2022 | -13.17 Mn |
| Dec 31, 2022 | -13.17 Mn |
| Dec 31, 2021 | -4.84 Mn |
| Dec 31, 2021 | -4.84 Mn |
| Sep 30, 2021 | 645,000.00 |
| Sep 30, 2021 | 645,000.00 |
| Jun 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 7.52 Mn |
| Mar 31, 2021 | 7.52 Mn |
| Dec 31, 2020 | -808,000.00 |
| Dec 31, 2020 | -808,000.00 |
| Sep 30, 2020 | 1.20 Mn |
| Sep 30, 2020 | 1.20 Mn |
| Jun 30, 2020 | 10,017.00 |
| Jun 30, 2020 | 10,017.00 |
| Mar 31, 2020 | -322,000.00 |
| Mar 31, 2020 | -322,000.00 |
| Dec 31, 2019 | 124,000.00 |
| Dec 31, 2019 | 124,000.00 |
| Sep 30, 2019 | 30,985.00 |
| Sep 30, 2019 | 30,985.00 |
| Mar 31, 2019 | 26,000.00 |
| Mar 31, 2019 | 26,000.00 |
| Dec 31, 2018 | -335,000.00 |
| Dec 31, 2018 | -335,000.00 |
| Sep 30, 2018 | 61,379.00 |
| Sep 30, 2018 | 61,379.00 |
| Jun 30, 2018 | 13,709.00 |
| Jun 30, 2018 | 13,709.00 |
| Mar 31, 2018 | -18,148.00 |
| Mar 31, 2018 | -18,148.00 |
| Dec 31, 2017 | -461,000.00 |
| Dec 31, 2017 | -461,000.00 |
| Sep 30, 2017 | 5.69 Mn |
| Sep 30, 2017 | 5.69 Mn |
| Jun 30, 2017 | 316,012.00 |
| Jun 30, 2017 | 316,012.00 |
| Mar 31, 2017 | -126,000.00 |
| Mar 31, 2017 | -126,000.00 |
| Dec 31, 2016 | -590,000.00 |
| Dec 31, 2016 | -590,000.00 |
| Sep 30, 2016 | 67,500.00 |
| Sep 30, 2016 | 67,500.00 |
| Jun 30, 2016 | 407,800.00 |
| Jun 30, 2016 | 407,800.00 |
| Mar 31, 2016 | 169,800.00 |
| Mar 31, 2016 | 169,800.00 |
| Dec 31, 2015 | -1.37 Mn |
| Dec 31, 2015 | -1.37 Mn |
| Jun 30, 2015 | 483,000.00 |
| Jun 30, 2015 | 483,000.00 |
| Mar 31, 2015 | 87,000.00 |
| Mar 31, 2015 | 87,000.00 |
| Dec 31, 2014 | 159,000.00 |
| Dec 31, 2014 | 159,000.00 |
| Sep 30, 2014 | -1,000.00 |
| Sep 30, 2014 | -1,000.00 |
| Jun 30, 2014 | -6,000.00 |
| Jun 30, 2014 | -6,000.00 |
| Mar 31, 2014 | 740,600.00 |
| Mar 31, 2014 | 740,600.00 |
| Dec 31, 2013 | 1,727.00 |
| Dec 31, 2013 | 1,727.00 |